2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theOpen-Angle Glaucoma (OAG) Market?

Increased consciousness around eye disorders is predicted to boost the progress of the open-angle glaucoma (OAG) market in the future. Eye disorders include a broad spectrum of health issues that affect the structure, function, or sight of the eyes, varying from minor problems like dry eye to grave conditions like glaucoma and macular degeneration. Factors such as aging populations, extended screen usage, rise in diabetes, environmental pollution, and lifestyle habits adversely impacting ocular health contribute to their prevalence. Open-angle glaucoma (OAG), a primary reason for blindness particularly in older populations, emphasizes the importance of regular eye checks, swift diagnosis, and preemptive treatment to prevent permanent vision damage. For example, in October 2023, the Royal National Institute of Blind People (RNIB), a sight loss charity based in the UK, stated that the number of eye care outpatient appointments in the UK in 2021/22 went beyond eight million, making it the most sought-after specialty. Moreover, the count of people suffering from sight loss, now exceeding two million, is anticipated to rise to over four million by 2050. Hence, increasing awareness about eye disorders is fueling the growth of the open-angle glaucoma (OAG) market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

#What is the Growth Potential of the Open-Angle Glaucoma (OAG) Market, and How Will It Perform by 2034?

Recent years have seen robust growth in the open-angle glaucoma (OAG) market size. Predicted to swell from $6.13 billion in 2024 to $6.55 billion in 2025, it is set to achieve a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth in the historic period include a heightened incidence of glaucoma amongst older populations, an increase in public awareness for early diagnosis of eye conditions, growing healthcare spending, the implementation of government-powered vision care initiatives, and the worldwide expansion of ophthalmology practices.

In the coming years, the open-angle glaucoma (OAG) market is anticipated to experience substantial growth, with a projected increase to $8.42 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.5%. The market growth during this forecast period can be credited to the escalating demand for combination treatments, an amplified focus on personalized healthcare, improvements in reimbursement policies for glaucoma procedures, an increased prevalence of ocular conditions due to lifestyle habits, and an emerging preference for non-invasive diagnostic techniques. Key trends during the forecast period are expected to include the expanding usage of AI in glaucoma diagnostics, a trend towards outpatient glaucoma surgical treatments, incremented use of sustained-release glaucoma implants, a growing incorporation of wearable technology in monitoring intraocular pressure, and an increased emphasis on sustainability in the manufacturing of medical devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theOpen-Angle Glaucoma (OAG) Market?

Significant market players in the open-angle glaucoma (OAG) industry are focusing more on the creation of new solutions, such as minimally invasive glaucoma devices (MIGDs), in order to offer better and less aggressive options for handling primary open-angle glaucoma. This also reduces the need for traditional treatments. These MIGDs include a variety of surgical procedures and implants, specifically developed to decrease intraocular pressure in glaucoma patients with minimal invasion and damage to eye tissues. In December 2023, for example, iSTAR Medical, a medtech firm from Belgium, introduced MINIject in the Netherlands. This innovative treatment for primary open-angle glaucoma employs a unique porous STAR material to boost fluid drainage and reduce IOP. MINIject represents an important shift in glaucoma care by offering a safer and more effective handling option for the primary cause of irreversible blindness. This also allows for a reduced reliance on the standard treatment methods.

Who Are the Key Market Players Influencing the Growth of the Corn and Open-Angle Glaucoma (OAG) Industry?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Key Market Segments Comprise the Open-Angle Glaucoma (OAG) Market and Drive Its Revenue Growth?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Which Regions Are Emerging as Leaders in the Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2025, By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia and Presbyopia Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: